Cargando…
Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa
INTRODUCTION: The use of hematopoietic cell transplantation (HCT) has previously been shown to ameliorate cutaneous blistering in pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB), an inherited skin disorder that results from loss-of-function mutations in COL7A1 and manifests...
Autores principales: | Perdoni, Christopher, McGrath, John A, Tolar, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446116/ https://www.ncbi.nlm.nih.gov/pubmed/25376815 http://dx.doi.org/10.1186/scrt511 |
Ejemplares similares
-
Clinical trial of ABCB5(+) mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2021) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014) -
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa
por: Tolar, Jakub, et al.
Publicado: (2013) -
Advances in understanding and treating dystrophic epidermolysis bullosa
por: Vanden Oever, Michael J, et al.
Publicado: (2014) -
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa
por: Webber, Beau R, et al.
Publicado: (2016)